AVID100 in Advanced Epithelial Carcinomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Ribociclib and Bicalutamide in AR+ TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating MM-310 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
- Status
- COMPLETED
- Phase
- PHASE1
Vaccination of Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2